Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Management of Chronic Lymphocytic Leukemia in 2020
EP. 1: Prognostic Factors in Patients With CLL
January 28th 2020
EP. 2: Mutation Status Throughout the CLL Clinical Course
January 28th 2020
EP. 3: Chemoimmunotherapy for CLL; Still a Role?
January 28th 2020
EP. 4: Long-Term Experience With BTK Inhibitors for CLL
January 28th 2020
EP. 5: Acalabrutinib, Second-Generation BTK Inhibitor for CLL
January 28th 2020
EP. 6: The Role of Venetoclax + Rituximab in CLL
January 28th 2020
EP. 7: Treatment for Younger Fit Patients With CLL
January 28th 2020
EP. 8: Ibrutinib + Venetoclax for CLL
January 28th 2020
EP. 9: Combining Targeted Therapies in CLL
January 28th 2020
EP. 10: Distinguishing Features Among BTK Inhibitors
January 28th 2020
EP. 11: Health Maintenance in CLL
January 28th 2020
EP. 12: Fixed-Duration Therapy for Relapsed CLL
January 28th 2020
EP. 13: Combinations for Relapsed or Refractory CLL
January 28th 2020
EP. 14: Resistance to Therapy in CLL
January 28th 2020
EP. 15: Management of CLL Progression After Ibrutinib
January 28th 2020
EP. 16: PI3 Kinase Inhibitors for Relapsed/Refractory CLL
January 28th 2020
EP. 17: Sequencing Strategies for CLL
January 28th 2020
EP. 18: CAR T-Cell Therapy for Relapsed/Refractory CLL
January 28th 2020
EP. 19: 2019 ASH; Best Abstracts for CLL
January 28th 2020